# Chemomab Therapeutics Ltd.: Form 6-K, filed May 6, 2026

- Company: [Chemomab Therapeutics Ltd.](/companies/cmmb.md) (CIK 1534248)
- Form: 6-K
- Filed: 2026-05-06
- Accepted by EDGAR: May 6, 2026, 17:03 ET
- Period: 2026-05-06
- Accession: 0001178913-26-002423
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1534248/000117891326002423/zk2635214.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1534248/000117891326002423/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1534248/000117891326002423/zk2635214.htm

Filed May 6, 2026.
Source: SEC EDGAR, the filing index for accession 0001178913-26-002423. Last ingested by Listed: Nov 3, 2026, 08:33 ET. No prices; not investment advice.